Green Synthesis of Copper Oxide Nanoparticles using Dolichandrone falcata (Wall.ex DC.) Seem. Leaf Extract and Assessment of Antioxidant, Antimicrobial, Anti-diabetic and Anticancer Potentials.
{"title":"Green Synthesis of Copper Oxide Nanoparticles using Dolichandrone falcata (Wall.ex DC.) Seem. Leaf Extract and Assessment of Antioxidant, Antimicrobial, Anti-diabetic and Anticancer Potentials.","authors":"MohamadYusuff Aysha, Kuppusamy Selvam, Ramachandran Adhavan, Palanisamy Prakash, Muthugounder Subaramanian Shivakumar","doi":"10.1007/s12010-025-05356-4","DOIUrl":null,"url":null,"abstract":"<p><p>Phyto-synthesis of Copper Oxide Nanoparticles (CuO NPs) was carried out using Dolichandrone falcata leaves. The NPs were characterised using Ultraviolet-Visible spectroscopy (UV), UV-Vis diffuse reflectance spectroscopy (UV-DRS), X-ray diffraction analysis (XRD), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR) and dynamic light scattering (DLS). The synthesised CuO NPs UV-Vis spectra revealed that a high absorption peak at 380 nm with optical band gap was 2.8 eV. The appearance of distinctive peaks in XRD pattern verified that CuO NPs were crystalline. Particle size distribution (DLS) revealed the average particle size 222 nm with Polydispersity Index (PDI) value is 0.348. The antibacterial ability of the synthesized CuO NPs was then investigated against major pathogens, including Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis). Antioxidant activity against DPPH 61.10% ± 0.90 IC<sub>50</sub> was 273.56 μg/mL, H<sub>2</sub>O<sub>2</sub> 64.36 ± 0.61% IC<sub>50</sub> was 145.43 μg/mL and metal chelating activity 68.20% ± 0.91 with IC<sub>50</sub> value 150.50 µg/mL. Anti-diabetic activity of α-amylase inhibition 75.30% ± 0.59 with IC<sub>50</sub> value 725.32 µg/mL and α-glucosidase inhibition 73.21% ± 0.45 with IC<sub>50</sub> value 540.40 µg/mL. Furthermore, the nanoparticle demonstrated anticancer effects with an IC<sub>50</sub> of 156.26 µg/mL against the skin cancer cell line A431.</p>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Biochemistry and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s12010-025-05356-4","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Phyto-synthesis of Copper Oxide Nanoparticles (CuO NPs) was carried out using Dolichandrone falcata leaves. The NPs were characterised using Ultraviolet-Visible spectroscopy (UV), UV-Vis diffuse reflectance spectroscopy (UV-DRS), X-ray diffraction analysis (XRD), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR) and dynamic light scattering (DLS). The synthesised CuO NPs UV-Vis spectra revealed that a high absorption peak at 380 nm with optical band gap was 2.8 eV. The appearance of distinctive peaks in XRD pattern verified that CuO NPs were crystalline. Particle size distribution (DLS) revealed the average particle size 222 nm with Polydispersity Index (PDI) value is 0.348. The antibacterial ability of the synthesized CuO NPs was then investigated against major pathogens, including Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis). Antioxidant activity against DPPH 61.10% ± 0.90 IC50 was 273.56 μg/mL, H2O2 64.36 ± 0.61% IC50 was 145.43 μg/mL and metal chelating activity 68.20% ± 0.91 with IC50 value 150.50 µg/mL. Anti-diabetic activity of α-amylase inhibition 75.30% ± 0.59 with IC50 value 725.32 µg/mL and α-glucosidase inhibition 73.21% ± 0.45 with IC50 value 540.40 µg/mL. Furthermore, the nanoparticle demonstrated anticancer effects with an IC50 of 156.26 µg/mL against the skin cancer cell line A431.
期刊介绍:
This journal is devoted to publishing the highest quality innovative papers in the fields of biochemistry and biotechnology. The typical focus of the journal is to report applications of novel scientific and technological breakthroughs, as well as technological subjects that are still in the proof-of-concept stage. Applied Biochemistry and Biotechnology provides a forum for case studies and practical concepts of biotechnology, utilization, including controls, statistical data analysis, problem descriptions unique to a particular application, and bioprocess economic analyses. The journal publishes reviews deemed of interest to readers, as well as book reviews, meeting and symposia notices, and news items relating to biotechnology in both the industrial and academic communities.
In addition, Applied Biochemistry and Biotechnology often publishes lists of patents and publications of special interest to readers.